Latest news with #7.8
Korea Herald
16 hours ago
- Health
- Korea Herald
New Global Aesthetics Report: A Shift Towards Facial Surgery Globally as Eyelid Ranks Top Procedure
Aesthetic Procedures Close to 38 Million in 2024. MOUNT ROYAL, N.J., June 20, 2025 /PRNewswire/ -- The International Society of Aesthetic Plastic Surgery (ISAPS) released the results of its annual Global Survey on Aesthetic/Cosmetic Procedures at the ISAPS Olympiad World Congress in Singapore, showing more than 17.4 million procedures performed by plastic surgeons and 20.5 non-surgical procedures. Over the last four years, the overall increase is 42.5%. Eyelid surgery, for the first time, was the most common surgical procedure in 2024, replacing liposuction, with 2.1 million, followed by liposuction, breast augmentation, scar revision, and rhinoplasty. The most popular non-surgical procedures were botulinum toxin, hyaluronic acid (filler), hair removal, non-surgical skin tightening, and chemical peels. Most face and head procedures showed growth from the previous year, with more than 7.4 million procedures and a 4.3% increase. Top procedures were eyelid surgery with more than 2.1 million and a 13.4% increase, rhinoplasty with 1 million procedures and a 10% decrease, and fat grafting – face 0.9 million and a 19.2% increase. There were 3.9 million breast procedures (-14.1%) and 6 million body and extremities procedures (-14.8%). Liposuction was still the most common surgical procedure for women, followed by eyelid surgery and breast augmentation. Eyelid surgery was again the most popular surgical procedure among men, followed by gynecomastia and scar revision. Most breast augmentations (54% of the total), rhinoplasties (60.1%), and external genital surgery (48.4%) took place on 18–34-year-olds, whereas botulinum toxin injectables were most popular among those aged 35–50 (47.0% of the total). Liposuction and non-surgical fat reduction were distributed quite evenly among both age groups. Botulinum toxin remained the most common non-surgical procedure for both men and women and among all age groups, with 7.8 million procedures performed by plastic surgeons worldwide. In second place, hyaluronic acid procedures increased by 5.2% to 7.8 million. Commenting on the global results, Dr. Amin Kalaaji, Chair of the ISAPS Global Survey Committee and plastic surgeon in Norway, said, "Our report now includes data on 'Mommy Makeover' and other combined procedures, scar revision, hand rejuvenation with fat grafting, buccal fat removal, inverted nipple correction, dimple creation, and other outer genital surgery." Once again, the US performed the most procedures with over 6.1 million, followed by Brazil with 3.1 million (which is first in surgical procedures), and Japan.
Yahoo
3 days ago
- Business
- Yahoo
5 Revealing Analyst Questions From Delta's Q1 Earnings Call
Delta's first quarter drew a positive market reaction, as investors responded to the airline's ability to generate steady revenue growth and maintain profitability in a turbulent operating environment. Management credited the quarter's performance to the continued resilience of higher-margin segments—particularly Premium cabins and Loyalty programs—as well as strong international travel demand. CEO Ed Bastian highlighted Delta's 'industry-leading reliability and premium service,' while President Glen Hauenstein noted, 'approximately 60% of our total revenue now comes from diverse, high-margin streams.' Despite softness in domestic Main Cabin demand and a more challenging macroeconomic backdrop, Delta's diversified revenue mix and operational discipline helped offset these headwinds. Is now the time to buy DAL? Find out in our full research report (it's free). Revenue: $14.04 billion vs analyst estimates of $13.88 billion (2.1% year-on-year growth, 1.1% beat) EPS (GAAP): $0.37 vs analyst expectations of $0.40 (6.9% miss) Adjusted EBITDA: $1.2 billion vs analyst estimates of $1.3 billion (8.5% margin, 7.8% miss) Revenue Guidance for Q2 CY2025 is $16.66 billion at the midpoint, roughly in line with what analysts were expecting EPS (GAAP) guidance for Q2 CY2025 is $2 at the midpoint, missing analyst estimates by 12.1% Operating Margin: 4.1%, in line with the same quarter last year Revenue Passenger Miles: 55.68 billion, up 1.47 billion year on year Market Capitalization: $32.3 billion While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention. Conor Cunningham (Melius Research) questioned whether ongoing domestic softness could spill over to Premium and International segments. President Glen Hauenstein explained they are monitoring closely but see no evidence of weakness outside the Main Cabin yet. Andrew Didora (Bank of America) asked about the timing and geographic focus of capacity cuts. Hauenstein clarified that reductions will begin in August, concentrated in the Southeast, and mainly affect off-peak Main Cabin flights. Catherine O'Brien (Goldman Sachs) probed how Delta can maintain cost targets while reducing capacity. CFO Dan Janki detailed strategies including flexible labor scheduling, maintenance timing, and supplier negotiations. Duane Pfennigwerth (Evercore) sought specifics on which fleet types are being retired and the drivers of loyalty growth. Hauenstein noted focus on retiring 757s, 767s, and older A319/A320s, and that loyalty growth is primarily from increased cardholder spend. Tom Fitzgerald (TD Cowen) inquired about competitive dynamics and risk of customer trade-down to low-cost carriers. Hauenstein argued Delta's strong brand and loyalty program should allow it to retain share, even as yields may fall. In coming quarters, the StockStory team will be watching (1) whether capacity reductions improve profitability on domestic routes, (2) the resilience of Premium and International demand as macro uncertainty persists, and (3) the ongoing impact of cost-cutting measures on margins and free cash flow. Fleet retirements, booking trends for summer travel, and the execution of new MRO contracts will also be important markers for Delta's performance. Delta currently trades at $48.19, up from $35.92 just before the earnings. Is there an opportunity in the stock?See for yourself in our full research report (it's free). Market indices reached historic highs following Donald Trump's presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth. While this has caused many investors to adopt a "fearful" wait-and-see approach, we're leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13-06-2025
- Health
- Yahoo
House tax-and-spending bill and other Trump administration changes could make millions of people lose their health insurance coverage
President Donald Trump has promised not to cut Medicaid many times over the past decade, including in the tax-and-spending legislative package he has made a top priority in his second administration. But several provisions in the bill, which the House of Representatives passed in a largely party-line 215-214 vote in May 2025, could cause millions of Americans enrolled in Medicaid to lose their health insurance coverage, according to the nonpartisan Congressional Budget Office. Medicaid is funded jointly by the federal government and the states. The program provides nearly 80 million Americans, most of whom are low-income or have disabilities, with health insurance. The legislation, which advances Trump's agenda, faces a tough battle in the Senate despite the Republican Party majority in that chamber. Several GOP senators have either said they oppose it or have expressed strong reservations for a variety of reasons, including the trillions of dollars the package would add to the U.S. government's debt. As a scholar who researches access to health care, I am concerned about the possibility that millions of people will lose their health insurance coverage should this bill become law. In many cases, that could occur due to new bureaucratic obstacles the bill would introduce. About 25.3 million Americans lacked insurance in 2023, down sharply from 46.5 million in 2010. Most of this 46% decline occurred because of the Affordable Care Act of 2010. The Congressional Budget Office, a nonpartisan agency that provides evidence-supported information to Congress, estimates that 10.9 million Americans would lose their health insurance by 2034 if the House of Representatives' version of that package were to become law. Of these, as many as 7.8 million would lose access to Medicaid. Another 2.1 million people who the CBO estimates would end up uninsured are Americans who today have coverage they bought in the marketplaces that the Affordable Care Act created. In addition to the measures in the tax-and-spending bill, other changes are looming. These include the expiration of some ACA-related measures adopted in 2021 that Trump does not intend to renew, and new regulations. All told, the number of Americans losing their health insurance by 2034 could total 16 million, according to the CBO. Other estimates suggest that the number of Americans losing their coverage could run even higher. The House bill would reduce incentives the federal government provides states to expand their Medicaid programs as part of the ACA. Eliminating these incentives would make it even less likely that Texas and the other nine states that still have not expanded Medicaid eligibility would do so in the future. The bill would also make it harder for states to come up with their share of Medicaid funding by limiting 'provider taxes.' These taxes are charged to hospitals, doctors and other medical providers. The revenue they raise help pay for the state's share of Medicaid costs. And the legislative package would also reduce federal funding to cover Medicaid costs in states that provide coverage to unauthorized immigrants using only their own funds. Threatened with billions in losses, the states that do this are unlikely to maintain these programs. In California alone, this would jeopardize the coverage of 1.6 million of its residents. Losing Medicaid coverage may leave millions of low-income Americans without insurance coverage, with no affordable alternatives for health care. Other proposed changes in the House bill would indirectly cut Medicaid coverage by forcing people to deal with more red tape to get or keep it. This would happen primarily through the introduction of 'work requirements' for Medicaid coverage. When enrolled in the program, applicants who are between 19 and 64 years old would need to certify they are working at least 80 hours a month or spending that much time engaged in comparable activities, such as community service. Work requirements specifically target people eligible for Medicaid through the Affordable Care Act's expansion of the program. They tend to have slightly higher incomes than the other people eligible for this benefit. Arkansas gave Medicaid work requirements a try during the first Trump administration. Researchers who studied what happened found that 1 in 4 of the Arkansans enrolled in Medicaid affected by the policy lost their health insurance coverage. They also found that in most cases, this occurred because of bureaucratic obstacles, and that the policy didn't lead to more people getting jobs. By some estimates, the work requirements provision alone would lead to close to 5 million people of the 7.8 million being denied Medicaid coverage. At the same time, the bill would increase how often Medicaid beneficiaries have to reapply to the program to keep their coverage from once every 12 months to twice a year. It also would delay or reverse several policies that made it easier for Americans to enroll in Medicaid and maintain their coverage. Many of those who aren't kicked out would also face either new or higher co-payments for appointments and procedures – restricting their access to health care, even if they don't wind up without insurance. There is ample evidence that obstacles like these make it hard to remain enrolled in safety net programs. Historically, the people who are most likely to lose their benefits are low-income, people of color or immigrants who do not speak English well. The bill would also affect the more than 24 million Americans who get health insurance through Affordable Care Act Marketplace plans. Changes in the House version of the bill would make it harder to get this coverage. This includes reducing the time Americans have to enroll in plans and eliminating certain subsidies. It also makes the enrollment process more complicated. Combined with other changes the Trump administration has made, experts expect Marketplace premiums to skyrocket. The Congressional Budget Office expects more than 2 million beneficiaries to lose coverage due to these new policies. Americans buying their own insurance on the ACA marketplaces may also face higher premiums. Increased subsidies in place since 2021 are set to expire at the end of the year. Combined with Trump regulatory decisions, this may lead to more than 5 million Americans losing coverage – whether or not the GOP's tax-and-spending package is enacted. The effects of the bill would also be compounded by further changes by individual states. This could include the introduction of monthly premiums that people with Medicaid coverage would have to pay, in Indiana and other states. Some states may also reduce eligibility for certain groups or cover fewer services, as states seek to reduce their Medicaid costs. And some states, including Iowa and Utah, are already pursuing work requirements on their own whether or not they become mandatory across the nation. If fewer Americans have health insurance due to changes the Trump administration is making and the policies embedded in the pending tax-and-spending legislative package, the health of millions of people could get worse due to forgone care. And at the same time, their medical debts could grow larger. This article is republished from The Conversation, a nonprofit, independent news organization bringing you facts and trustworthy analysis to help you make sense of our complex world. It was written by: Simon F. Haeder, Texas A&M University Read more: US health care is rife with high costs and deep inequities, and that's no accident – a public health historian explains how the system was shaped to serve profit and politicians There's no evidence work requirements for Medicaid recipients will boost employment, but they are a key piece of Republican spending bill Work requirements are better at blocking benefits for low-income people than they are at helping those folks find jobs Dr. Simon F. Haeder has previously received funding from the Centers for Medicare and Medicaid Services, the Pennsylvania Insurance Department, and the Robert Wood Johnson Foundation for unrelated projects.
Yahoo
28-05-2025
- Business
- Yahoo
Strauss Group Reports First Quarter 2025 Results: Revenues up 15.5%, reaching NIS 3 billion Operating profit amounted to NIS 181 million[1]
First Quarter 2025 Highlights: Sales growth across all business segments in Israel and globally, driven primarily by Brazil Continued investment in infrastructure in Israel, including a new production facility for plant-based milk alternatives in Northern Israel (expected to be completed by the end of 2025), and new logistics centers in Bror Hayil and Yotvata Growth in Israel across all segments, driven by innovation and a customer-centric approach The international coffee business achieved record revenues and operating profit in the quarter In Brazil, the group continues to maintain its leading competitive position in coffee and presented an improvement in its operating profit. Strauss Water launched a new brand in the UK, in collaboration with Culligan S&P Maalot affirmed the Group's ilAA+ rating with stable outlook PETAH TIKVA, Israel, May 28, 2025 /PRNewswire/ -- Strauss Group Ltd. (TASE: STRS) reported its financial statements for the first quarter of 2025, highlighting significant revenue growth despite ongoing inflationary pressures in raw material costs, particularly coffee and cocoa. Strauss Group President & CEO Shai Babad commented: "In the first quarter. Strauss Group achieved significant growth in all activities, while improving market share in main categories. This growth was driven across the board by strengthening our position as the leading coffee company in Brazil and leaning into consumer centric trends in Israel, introducing product innovation that powers our popular brands. Likewise, we have continued our commitment to Israeli industry, investing in manufacturing facilities and logistics centers in the North and South of the country. We recently laid the cornerstone for a new logistics center in Bror Hayil, and later this year we intend to launch a new production facility for plant-based milk alternatives in the North. "The Group remains focused on the consistent execution of our strategic plan, while facing the ongoing pressure of high raw material costs and are committed to delivering sustainable growth and value to our consumers." Key financial indicators: NIS millions Q1 2025 Q1 2024 % Change Sales 2,990 2,589 +15.5 % Operating profit 181 204 -11.2 % Operating margin % 6.0 % 7.8 %Net profit 73 159 -54.8 % Net margin % 2.4 % 6.2 % Strauss Group released its financial statements for the first quarter of 2025, reporting sales of approximately NIS 3 billion, representing 15.5% growth compared to the same quarter last year. Growth was primarily driven by the international coffee business, with Brazil in particular, in addition to ongoing growth in Israel and Strauss Water, with volume growth achieved in some of the business segments. The Group's operating profit reached NIS 181 million, 6.0% of sales, compared to NIS 204 million, 7.8% of sales in the first quarter last year. Operating profit was impacted by rising raw material costs, particularly green coffee and cocoa. Net profit amounted to NIS 73 million, 2.4% of the sales. In parallel, and as part of its strategic plan, the Group delivered operational efficiencies through the implementation of productivity initiatives. Excluding a non-recurring loss on cocoa derivatives of NIS 49m, the gross profit would have reached NIS 830m, reflecting a 27.7% margin. Quarterly summary by operating segment: Strauss Israel – 6.6% growth in Q1 2025 Strauss Israel concluded the quarter with revenue of NIS 1.4 billion, an increase of 6.6%, yoy. Strauss Israel's operating profit was NIS 113 million, reflecting a decline of 25.7%, yoy. The decline in profitability was mainly due to rising coffee and cocoa prices and realization of a non-recurring loss of NIS 49m on cocoa derivatives. Health & Wellness segment sales reached NIS 742 million, up 1.5%, yoy, while the segment's operating profit reached NIS 88 million, an increase of 18.2%. Fun & Indulgence (Snacks and Confectionery) segment sales reached NIS 394 million, up 9.2%, yoy. The segment reported an operating loss of NIS 16 million, of which NIS 49 million is attributable to the realization of non-recurring loss on cocoa derivatives. Fun & Indulgence (Israel Coffee) segment sales reached NIS 260 million, up 19.4%, yoy, with the segment's operating profit reaching NIS 41 million, an increase of 15.5%, yoy. Strauss International Coffee – 45.4% growth in Q1 2025 In Q1 2025, Strauss Coffee's sales reached NIS 1.4 billion, representing an increase of 45.4%, yoy. Operating profit reached NIS 55 million, an increase of 43.9%, yoy, with an operating margin of 3.9%. The Group's coffee activity in Central Eastern Europe – Poland, Romania, Russia and Ukraine – delivered sales growth during the quarter moderated by the impact of exchange rates. Sales of the coffee company in Brazil, Três Corações (50% owned) reached NIS 1,008 million, up 56.4%, yoy, while operating profit reached NIS 30 million, an increase of 133.1%, yoy. Strauss Water – 6.9% growth in Q1 2025 Strauss Water continued to grow in the first quarter of 2025, reaching revenues of NIS 206 million, an increase of 6.9%, yoy. Operating profit reached NIS 26 million, up 8.7%, yoy, with an operating margin of 12.5%. The Group's water business in China (in partnership with Haier) concluded the quarter with sales of NIS 227 million, an increase of 5.2%, yoy, and reached net profit of NIS 31 million, representing an increase of 16.5%, yoy, (based on 100% ownership). Following are key sales figures, by business segment, based on the company's management (non-GAAP) reports(1) (in NIS m):First Quarter2025 2024 % Change % Change excluding FX Sales Strauss Israel Health & Wellness 742 731 1.5 % 1.5 % Fun & Indulgence (Snacks and sweets) (2) 394 361 9.2 % 9.2 % Fun & Indulgence (Coffee Israel) (2) 260 217 19.4 % 19.4 % Total Strauss Israel 1,396 1,309 6.6 % 6.6 % Total International Coffee(2) 1,388 954 45.4 % 65.0 % Strauss Water(2) 206 193 6.9 % 7.0 % Other (3) - 133 -100.0 % -100.0 % Total Group 2,990 2,589 15.5 % 20.9 % (1) The data presented in this document are based on the company's non-GAAP figures, which include the proportionate consolidation of jointly controlled entities and exclude the following: share-based payments; end-of-period mark-to-market valuations of open financial derivative positions used for commodity hedging; timing adjustments for gains and losses from commodity derivatives, which are deferred until the related inventory is sold to third parties and/or the derivative is exercised; other net income and expenses; and the related tax effects, unless stated otherwise. All changes are in comparison with the corresponding period last year, unless stated otherwise. (2) Fun & Indulgence (Snacks and Confectionery) figures include Strauss's 50% interest in the salty snacks business. International Coffee figures include Strauss's 50% interest in the Três Corações joint venture (3C) in Brazil (a company jointly held by the Group (50%) and by the local São Miguel Group (50%)). Strauss Water EBIT figures include Strauss's interest in Haier Strauss Water (HSW) in China (49%). (3) Comparative figures include the data for Sabra and Obela (based on 50%), which were sold during 2024. Note: Financial data were rounded to the nearest NIS million. Percentages changes were calculated based on the exact figures in NIS thousands. The figures for total International Dips & Spreads were derived from the exact figures for Sabra and Obela, in NIS thousands. Following are key operating profit figures, by business segment, based on the company's management (non-GAAP) reports(1) (in NIS m):First Quarter2025 2024 % Change Strauss Israel:Health & Wellness 88 74 18.2 % Operating Margin (%) 11.9 % 10.2 %Fun & Indulgence (Snacks and Sweets)(2)(4) -16 42 -139.5 % Operating Margin (%) -4.2 % 11.5 %Fun & Indulgence (Coffee Israel) (2) 41 35 15.5 % Operating Margin (%) 15.7 % 16.3 %Total Strauss Israel 113 151 -25.7 % Operating Margin (%) 8.1 % 11.6 %Total International Coffee (2) 55 38 43.9 % Operating Margin (%) 3.9 % 4.0 %Strauss Water (2) 26 24 8.7 % Operating Margin (%) 12.5 % 12.3 %Other (3) -13 -9 25.8 % Total Group 181 204 -11.2 % Operating Margin (%) 6.0 % 7.8 %(1) The data presented in this document are based on the company's non-GAAP figures, which include the proportionate consolidation of jointly controlled entities and exclude the following: share-based payments; end-of-period mark-to-market valuations of open financial derivative positions used for commodity hedging; timing adjustments for gains and losses from commodity derivatives, which are deferred until the related inventory is sold to third parties and/or the derivative is exercised; other net income and expenses; and the related tax effects, unless stated otherwise. All changes are in comparison with the corresponding period last year, unless stated otherwise. (2) Fun & Indulgence (Snacks and Confectionery) figures include Strauss's 50% interest in the salty snacks business. International Coffee figures include Strauss's 50% interest in the Três Corações joint venture (3C) in Brazil (a company jointly held by the Group (50%) and by the local São Miguel Group (50%)). Strauss Water EBIT figures include Strauss's interest in Haier Strauss Water (HSW) in China (49%). (3) Comparative figures include the data for Sabra and Obela (based on 50%), which were sold during 2024. (4) The decrease to a loss of approximately 16 million shekels in the Fun & Indulgence (Snacks and sweets) is mainly due to a one-time loss in derivative activities. Following are key financial data, based on the company's management (non-GAAP) reports(1) (in NIS m): First Quarter2025 2024 % Change Total Group Sales 2,990 2,589 15.5 % Organic Sales Growth excluding FX 20.9 % -0.7 %Gross Profit 781 874 -10.6 % Gross Margins (%) 26.1 % 33.7 % -760 bps EBIT 181 204 -11.2 % EBIT Margins (%) 6.0 % 7.8 % -180 bps Net Income Attributable to the Company's Shareholders 73 159 -54.8 % Net Income Margin Attributable to the Company's Shareholders (%) 2.4 % 6.2 % -380 bps EPS (NIS) 0.62 1.37 -54.8 % EBITDA 282 318 -11.1 % EBITDA Margins (%) 9.4 % 12.3 % -290 bps Operating Cash Flow -347 -115 201.7 % Capex (2) -148 -163 -9.2 % Net debt 2,652 2,789 -4.9 % Net debt / EBITDA 2.3x 2.3x 0.0x Sales The company's sales in Q1-2025 reached NIS 2,990 million, an increase of 15.5% compared to the first quarter of 2024. Excluding the impact of exchange rates, sales increased by 20.9%. During 2024, the company completed several divestments, including the sale of the coffee business in Serbia, the fresh vegetables business in Bror Hayil, and the international dips and spreads business (Sabra & Obela). Excluding these discontinued operations, sales increased by 23.3%. Sales growth was largely driven by price increases across several categories and geographies, implemented in response to rising raw material costs. In addition, the Fun & Indulgence (Snacks and Confectionery) and the Fun & Indulgence (Israel Coffee) segments recorded growth due to higher sales volumes, the timing of Passover, and recovery from the war. Growth was also achieved in the International Coffee segment following price increases, which was moderated by the negative impact of exchange rates with the strengthening of the shekel against all currencies, particularly the Brazilian Real. Gross profit Gross profit in Q1 2025 declined by 10.6% reaching NIS 781 million, 26.1% of sales, compared to gross profit in Q1-24 of NIS 874 million, 33.7% of sales. The decline in gross profit and gross margin was primarily driven by higher raw material costs (particularly cocoa and green coffee), the sale of the dips and spreads business and realization of a non-recurring loss of NIS 49m on cocoa derivatives. These effects were partially offset by the growth in sales. Operating profit Operating profit in Q1-2025 declined by 11.2% to NIS 181 million, representing 6.0% of sales, compared to operating profit Q1-2024 of NIS 204 million, 7.8% of sales. The decline in operating profit and the operating margin was due to the lower gross profit, moderated by productivity initiatives implemented by the company, lower selling and marketing expenses in the Israel and International Coffee segments, reduced IT and payroll expenses, and the divestment of the dips and spreads business. Income attributable to shareholders of the company In Q1-2025, income attributable to shareholders of the company amounted to NIS 73 million, representing 2.4% of the sales, in comparison to NIS 159 million, 6.2% of sales in Q1-2024. The decline was primarily the result of lower operating profit and timing differences in tax expenses. Following are key financial data, based on the company's GAAP reports (in NIS m): First Quarter2025 2024 % Change Sales 1,887 1,726 9.3 % Cost of sales excluding impact of commodity hedges 1,299 1,090 19.1 % Adjustments for commodity hedges -24 71Cost of sales 1,275 1,161 9.8 % Gross profit 612 565 8.3 % % of sales 32.4 % 32.7 %Selling and marketing expenses 340 353 -3.7 % General and administrative expenses 121 129 -6.3 % Total expenses 461 482 -4.4 % Share of profit of equity-accounted investees 47 36 30.8 % Share of loss of equity-accounted incubator investees -8 -2 300.0 % Operating profit before other expenses 190 117 62.6 % % of sales 10.1 % 6.8 %Other expenses, net -9 -50Operating profit after other expenses 181 67 168.6 % Financing expenses, net -13 -17 -26.3 % Income before taxes on income 168 50 235.9 % Taxes on income -57 21Effective tax rate 34.2 % -41.4 %Income for the period 111 71 56.3 % Attributable to the Company's shareholders 86 51 67.8 % Attributable to non-controlling interests 25 20 26.4 % Webinar Earnings Call On Wednesday, May 28th, 2025, at 14:00 Israel time/12:00 UK time/7:00 a.m. ET, Strauss Group will host a webinar earnings call in Hebrew to review the financial statements of the company. The webinar will be hosted by the company's management. To participate in the webinar please use the following link: Webinar ID: 812 7646 3271 In addition, on Wednesday, May 28th, 2025, at 15:30 Israel time/13:30 UK time/8:30 a.m. ET, Strauss Group will host a webinar earnings call in English to review the financial statements of the company. The webinar will be hosted by the company's management. To participate in the webinar please use the following link: Webinar ID: 871 1664 0032 Questions for the questions and answers session may be submitted in advance to: ir@ Management's review will be accompanied by a presentation which will be available on the Investor Relations section of our website on Wednesday, May 28th, 2025: / Strauss Group's Q1 2025 earnings press release and financial statements will be available on the Company's website: / A recording of the webinar will be available on the company's website shortly following the webinar. For further information, please contact:Telem Yahav Director of External Communications 972-52-257-9939 972-3-675-6713 Rivka Neufeld Investor Relations Manager +972-54-4224146 Ben Yaakov Director of Communications and PR 972-54-609-1600 972-3-675-2584 Forward Looking Statement Disclaimer This press release does not constitute an offering to purchase or sell securities of Strauss Group Ltd. (the "Company") or an offer for the receipt of such offerings. The press release's sole purpose is to provide information. The Information provided in the press release concerning the analysis of the Company's activity is only an extract, and in order to receive a complete picture of the Company's activity and the risks it faces, one should review the Company's reports to the Israel Securities Authority and the Tel Aviv Stock Exchange. The press release may contain forward-looking statements as defined in the Israeli Securities Law, 5728-1968. All forward-looking statements in this press release are made based on the Company's current expectations, evaluations and forecasts, and actual results may differ materially from those anticipated, in whole or in part, as a result of different factors including, but not limited to, changes in market conditions and in the competitive and business environment, regulatory changes, currency fluctuations or the occurrence of one or more of the Company's risk factors. In addition, forward-looking forecasts and evaluations are based on information in the Company's possession while preparing the press release. The Company does not undertake any obligation to update forward-looking forecasts and evaluations made herein to reflect events and/or circumstances that may occur after this press release was prepared. GAAP to Non-GAAP Reconciliations In addition to reporting financial results in accordance with generally accepted accounting principles (GAAP), the Company provides non-GAAP operating results which include the results of jointly controlled entities as if they were proportionately consolidated. Strauss Group has a number of jointly controlled companies: the Três Corações joint venture (3C) - Brazil (a company jointly held by Strauss Group (50%) and by the São Miguel Group (50%) in Brazil), Strauss Frito-Lay Ltd. (a 50%/50% JV with PepsiCo Frito-Lay in Israel) and until the completion of the sale in December 2024, Sabra Dipping Company (a 50%/50% JV with PepsiCo in the U.S. and Canada)("Sabra"), and PepsiCo Strauss Fresh Dips & Spreads International(1) (a 50%/50% JV with PepsiCo outside the U.S. and Canada) ("Obela"). For more information on this sale, please refer to the Description of the Company's Business Report for 2024, section 11.1. In addition, non-GAAP figures exclude any share-based payments, mark to market of commodity hedging transactions as at end-of-period, other expenses or income and taxes referring to these adjustments. Company Management believes that these measures provide investors with transparency by helping to illustrate the underlying financial and business trends relating to the Company's results of operations and financial position and comparability between current and prior periods. Management uses these measures to establish and monitor budgets and operational goals and to evaluate the performance of the Company. Please see the GAAP to non-GAAP reconciliation tables in the Company's MD&A Report for a full reconciliation of the Company's GAAP to non-GAAP results. [1] The data presented in this document are based on the company's non-GAAP figures, which include the proportionate consolidation of jointly controlled entities and exclude the following: share-based payments; end-of-period mark-to-market valuations of open financial derivative positions used for commodity hedging; timing adjustments for gains and losses from commodity derivatives, which are deferred until the related inventory is sold to third parties; other net income and expenses; and the related tax effects, unless stated otherwise. All changes are in comparison with the corresponding period last year, unless stated otherwise. View original content: SOURCE Strauss Group Ltd. Sign in to access your portfolio
Yahoo
07-05-2025
- Business
- Yahoo
Park-Ohio (NASDAQ:PKOH) Reports Sales Below Analyst Estimates In Q1 Earnings
Diversified manufacturing and supply chain services provider Park-Ohio (NASDAQ:PKOH) missed Wall Street's revenue expectations in Q1 CY2025, with sales falling 2.9% year on year to $405.4 million. The company's full-year revenue guidance of $1.65 billion at the midpoint came in 1.5% below analysts' estimates. Its non-GAAP profit of $0.66 per share was 21% below analysts' consensus estimates. Is now the time to buy Park-Ohio? Find out in our full research report. Park-Ohio (PKOH) Q1 CY2025 Highlights: Revenue: $405.4 million vs analyst estimates of $425.5 million (2.9% year-on-year decline, 4.7% miss) Adjusted EPS: $0.66 vs analyst expectations of $0.84 (21% miss) Adjusted EBITDA: $33.9 million vs analyst estimates of $36.75 million (8.4% margin, 7.8% miss) Adjusted EPS guidance for the full year is $3.25 at the midpoint, roughly in line with what analysts were expecting Operating Margin: 4.7%, down from 6.1% in the same quarter last year Free Cash Flow was -$19.5 million compared to -$7.1 million in the same quarter last year Market Capitalization: $289.7 million Company Overview Based in Cleveland, Park-Ohio (NASDAQ:PKOH) provides supply chain management services, capital equipment, and manufactured components. Sales Growth A company's long-term sales performance is one signal of its overall quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul. Unfortunately, Park-Ohio struggled to consistently increase demand as its $1.64 billion of sales for the trailing 12 months was close to its revenue five years ago. This wasn't a great result and is a sign of poor business quality. Park-Ohio Quarterly Revenue We at StockStory place the most emphasis on long-term growth, but within industrials, a half-decade historical view may miss cycles, industry trends, or a company capitalizing on catalysts such as a new contract win or a successful product line. Park-Ohio's annualized revenue growth of 2.7% over the last two years is above its five-year trend, but we were still disappointed by the results. Park-Ohio Year-On-Year Revenue Growth This quarter, Park-Ohio missed Wall Street's estimates and reported a rather uninspiring 2.9% year-on-year revenue decline, generating $405.4 million of revenue. Looking ahead, sell-side analysts expect revenue to grow 4.5% over the next 12 months. Although this projection indicates its newer products and services will spur better top-line performance, it is still below the sector average. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) stock benefiting from the rise of AI. Click here to access our free report one of our favorites growth stories.
